Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
Clinical trial NCT02581137 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02581137
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-10
- Primary completion
- 2017-10-12
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.